The Future is Bright

The doctors and researchers at Duke Cancer Institute see a brighter future ahead for pancreatic cancer patients.

From new types of immunotherapy to clinical trials for KRAS, these doctors believe that pancreatic cancer has reached a turning point. Their research is leading to changes on the horizon for prevention, early detection, and treatments, which will lead to more and more long-term survivors.